Connection

MIEN-CHIE HUNG to Cell Movement

This is a "connection" page, showing publications MIEN-CHIE HUNG has written about Cell Movement.
Connection Strength

1.329
  1. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol. 2006 Oct; 26(19):7269-82.
    View in: PubMed
    Score: 0.166
  2. GSK3? inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. Oncotarget. 2016 Aug 30; 7(35):57131-57144.
    View in: PubMed
    Score: 0.082
  3. AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation. Cancer Res. 2016 Mar 15; 76(6):1451-62.
    View in: PubMed
    Score: 0.079
  4. De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells. Oncotarget. 2014 Nov 15; 5(21):10558-70.
    View in: PubMed
    Score: 0.073
  5. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer. Ann Surg Oncol. 2015 Mar; 22(3):889-98.
    View in: PubMed
    Score: 0.072
  6. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLoS Genet. 2014 Feb; 10(2):e1004177.
    View in: PubMed
    Score: 0.069
  7. Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking. Oncogene. 2014 Feb 06; 33(6):756-70.
    View in: PubMed
    Score: 0.064
  8. Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion. Mol Ther. 2012 Dec; 20(12):2326-34.
    View in: PubMed
    Score: 0.063
  9. Hepatitis B virus X protein induces IKKa nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells. J Cell Physiol. 2012 Apr; 227(4):1446-54.
    View in: PubMed
    Score: 0.061
  10. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol. 2012 Mar 11; 14(4):366-74.
    View in: PubMed
    Score: 0.060
  11. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol. 2011 Jan; 13(1):87-94.
    View in: PubMed
    Score: 0.055
  12. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene. 2011 Jan 27; 30(4):457-70.
    View in: PubMed
    Score: 0.055
  13. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res. 2010 Jun 15; 70(12):5096-108.
    View in: PubMed
    Score: 0.053
  14. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer. Oncogene. 2021 02; 40(7):1375-1389.
    View in: PubMed
    Score: 0.028
  15. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway. Theranostics. 2020; 10(10):4627-4643.
    View in: PubMed
    Score: 0.026
  16. Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death Dis. 2019 06 03; 10(6):432.
    View in: PubMed
    Score: 0.025
  17. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018 12; 50(12):1705-1715.
    View in: PubMed
    Score: 0.024
  18. MZF-1/Elk-1 interaction domain as therapeutic target for protein kinase Ca-based triple-negative breast cancer cells. Oncotarget. 2016 Sep 13; 7(37):59845-59859.
    View in: PubMed
    Score: 0.021
  19. Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis. Sci Rep. 2016 08 10; 6:31398.
    View in: PubMed
    Score: 0.021
  20. A Positive TGF-?/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer. Neoplasia. 2016 06; 18(6):371-86.
    View in: PubMed
    Score: 0.020
  21. Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget. 2016 May 03; 7(18):25742-54.
    View in: PubMed
    Score: 0.020
  22. The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun. 2015 Jun 17; 6:7351.
    View in: PubMed
    Score: 0.019
  23. Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation. Mol Cell. 2014 Jun 19; 54(6):960-974.
    View in: PubMed
    Score: 0.018
  24. Block-Cell-Printing for live single-cell printing. Proc Natl Acad Sci U S A. 2014 Feb 25; 111(8):2948-53.
    View in: PubMed
    Score: 0.017
  25. The anti-tumor activity of E1A and its implications in cancer therapy. Arch Immunol Ther Exp (Warsz). 2014 Jun; 62(3):195-204.
    View in: PubMed
    Score: 0.017
  26. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. Cancer Res. 2013 Nov 01; 73(21):6516-25.
    View in: PubMed
    Score: 0.017
  27. Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27. PLoS One. 2012; 7(11):e49605.
    View in: PubMed
    Score: 0.016
  28. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med. 2012 Oct; 18(10):1511-7.
    View in: PubMed
    Score: 0.016
  29. Identification of a GaG??, AKT and PKCa signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition. Int J Oncol. 2012 Jul; 41(1):189-200.
    View in: PubMed
    Score: 0.015
  30. CARMA3 is crucial for EGFR-Induced activation of NF-?B and tumor progression. Cancer Res. 2011 Mar 15; 71(6):2183-92.
    View in: PubMed
    Score: 0.014
  31. 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell. 2009 Sep 08; 16(3):195-207.
    View in: PubMed
    Score: 0.013
  32. Kr?ppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res. 2007 Aug 01; 67(15):7184-93.
    View in: PubMed
    Score: 0.011
  33. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell. 2006 Mar; 9(3):209-23.
    View in: PubMed
    Score: 0.010
  34. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. Mol Ther. 2005 Oct; 12(4):634-43.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.